Market revenue in 2023 | USD 1,032.0 million |
Market revenue in 2030 | USD 1,790.8 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Insulin delivery devices |
Fastest growing segment | Insulin Delivery Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Blood Glucose Monitoring (BGM) Devices, Insulin Delivery Devices |
Key market players worldwide | Medtronic PLC, Abbott Laboratories, Roche Holding AG, Bayer AG, Johnson & Johnson, B. Braun, DexCom Inc, Insulet Corp, Ypsomed Holding AG, Sanofi SA, Novo Nordisk A/S ADR, Arkray |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes devices market will help companies and investors design strategic landscapes.
Insulin delivery devices was the largest segment with a revenue share of 54.19% in 2023. Horizon Databook has segmented the Middle East & Africa diabetes devices market based on blood glucose monitoring (bgm) devices, insulin delivery devices covering the revenue growth of each sub-segment from 2018 to 2030.
The diabetes devices market in MEA is expected to witness rapid growth due to increased prevalence of diabetes and rapidly aging population, as well as growing demand for home-based monitoring devices. According to the International Diabetes Federation (IDF), the Middle East accounted for the second highest deaths due to diabetes among patients below 60 years.
Despite significant factors driving the penetration of digital patient monitoring devices, stringent regulatory framework and lack of proper reimbursement policies are anticipated to restrain the market growth. The prevalence of diabetes is increasing mainly due to unhealthy lifestyle and risk factors like obesity, genetics, lack of proper awareness, and high cost of care.
A sudden spike in the diabetic population was reported in the Middle East region. Studies suggest that Kuwait, Saudi Arabia, and Bahrain rank in the top 10 countries with the highest prevalence of diabetes in the world. Thus, extensive government policies and diabetic care plans are needed to reduce the prevalence in this region, thereby driving the adoption of effective blood glucose monitoring devices.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa diabetes devices market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa diabetes devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account